CareFusion, a medical technology company, has announced it has acquired Vestara, a California-based company focused on developing solutions for the management of pharmaceutical waste. The company said ...

SAN DIEGO, June 24, 2013 /PRNewswire/ -- CareFusion Corp. (NYSE: CFN), a leading, global medical technology company, today announced that 14 additional hospitals across the country have adopted the ...

SAN DIEGO, Dec. 7 CareFusion (NYSE: CFN), a leading, global medical device company, today announced six new Pyxis® medication management products at the 44th American Society for Health System ...

To view the multimedia assets associated with this release, please visit: http://www.multivu.com/mnr/53365-carefusion-unveils-pyxis-automated-medication-dispensing ...

CareFusion, a global medical device company, and Cerner Corp., a global provider of healthcare solutions and services, have announced an agreement to improve data communication between CareFusion ...

When patients begin receiving care at St. Luke's Same Day Surgery Center in April, they'll receive medications through a computerized pharmacy system that's been in use throughout St. Luke's Regional ...

BD received a warning letter after the Food and Drug Administration found fault with the practices at a facility that manufactures Pyxis medication management system medical devices. The letter, which ...

Pyxis Oncology has plenty to do with three antibody-drug conjugates in the pipeline, so the upstart biotech has formed a new joint venture called Kyma Therapeutics with Alloy Therapeutics to develop ...

Stephens has initiated coverage on Pyxis Oncology Inc (NASDAQ:PYXS), highlighting the company’s technology platform aimed at developing next-gen antibody-drug conjugates (ADCs) with enhanced potency, ...

Pyxis Oncology is aiming to close out a transformative 2021 with an IPO. Having licensed a pair of antibody-drug conjugates (ADCs) from Pfizer and raised a megaround to develop them, Pyxis is now ...

CAMBRIDGE, Mass., March 16, 2023 (GLOBE NEWSWIRE) -- Pyxis Oncology, Inc. (Nasdaq: PYXS), a clinical-stage company focused on developing next-generation therapeutics to target difficult-to-treat ...